Cargando…

Primary malignant melanoma

Malignant melanomas (MM) of the oral cavity are extremely rare, accounting for 0.2% to 8.0% of all malignant melanomas. Malignant melanomas is more frequently seen at the level of the hard palate and gingiva. Early diagnosis and treatment are important for reducing morbidity. Malignant melanoma cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Mısır, A. Ferhat, Durmuşlar, Mustafa C., Zerener, Tamer, Gün, Banu D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852024/
https://www.ncbi.nlm.nih.gov/pubmed/27052289
http://dx.doi.org/10.15537/smj.2016.4.15017
_version_ 1782429878483681280
author Mısır, A. Ferhat
Durmuşlar, Mustafa C.
Zerener, Tamer
Gün, Banu D.
author_facet Mısır, A. Ferhat
Durmuşlar, Mustafa C.
Zerener, Tamer
Gün, Banu D.
author_sort Mısır, A. Ferhat
collection PubMed
description Malignant melanomas (MM) of the oral cavity are extremely rare, accounting for 0.2% to 8.0% of all malignant melanomas. Malignant melanomas is more frequently seen at the level of the hard palate and gingiva. Early diagnosis and treatment are important for reducing morbidity. Malignant melanoma cells stain positively with antibodies to human melanoma black 45, S-100 protein, and vimentin; therefore, immunohistochemistry can play an important role in evaluating the depth of invasion and the location of metastases. A 76-year-old man developed an oral malignant melanoma, which was originally diagnosed as a bluish reactive denture hyperplasia caused by an ill-fitting lower denture. The tumor was removed surgically, and histopathological examination revealed a nodular-type MM. There was no evidence of recurrence over a 4-year follow-up period.
format Online
Article
Text
id pubmed-4852024
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Saudi Medical Journal
record_format MEDLINE/PubMed
spelling pubmed-48520242016-05-12 Primary malignant melanoma Mısır, A. Ferhat Durmuşlar, Mustafa C. Zerener, Tamer Gün, Banu D. Saudi Med J Case Report Malignant melanomas (MM) of the oral cavity are extremely rare, accounting for 0.2% to 8.0% of all malignant melanomas. Malignant melanomas is more frequently seen at the level of the hard palate and gingiva. Early diagnosis and treatment are important for reducing morbidity. Malignant melanoma cells stain positively with antibodies to human melanoma black 45, S-100 protein, and vimentin; therefore, immunohistochemistry can play an important role in evaluating the depth of invasion and the location of metastases. A 76-year-old man developed an oral malignant melanoma, which was originally diagnosed as a bluish reactive denture hyperplasia caused by an ill-fitting lower denture. The tumor was removed surgically, and histopathological examination revealed a nodular-type MM. There was no evidence of recurrence over a 4-year follow-up period. Saudi Medical Journal 2016-04 /pmc/articles/PMC4852024/ /pubmed/27052289 http://dx.doi.org/10.15537/smj.2016.4.15017 Text en Copyright: © Saudi Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mısır, A. Ferhat
Durmuşlar, Mustafa C.
Zerener, Tamer
Gün, Banu D.
Primary malignant melanoma
title Primary malignant melanoma
title_full Primary malignant melanoma
title_fullStr Primary malignant melanoma
title_full_unstemmed Primary malignant melanoma
title_short Primary malignant melanoma
title_sort primary malignant melanoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852024/
https://www.ncbi.nlm.nih.gov/pubmed/27052289
http://dx.doi.org/10.15537/smj.2016.4.15017
work_keys_str_mv AT mısıraferhat primarymalignantmelanoma
AT durmuslarmustafac primarymalignantmelanoma
AT zerenertamer primarymalignantmelanoma
AT gunbanud primarymalignantmelanoma